This is a Multicenter, observational, non-interventional registry designed to collect clinical data in Chinese patients who have received CUBICIN treatment under condition of actual usage in clinical practice.

MC MD

Inclusion Criteria:

• Patient has received CUBICIN treatment, decided by treating physician
• A patient who is considered as ethnic Chinese
• Provision of subject informed consent

Exclusion Criteria:

• A patient record will not be eligible for the registry database if the patient received CUBICIN as part of a controlled clinical study for the current infection episode.

Chinese patients received CUBICIN treatment